Overview

A Study to Evaluate the Effects of Renal Impairment on the Pharmacokinetics of ELX-02

Status:
Completed
Trial end date:
2019-08-07
Target enrollment:
Participant gender:
Summary
Phase 1 - Pharmacokinetics in Patients with Impaired Renal Function
Phase:
Phase 1
Details
Lead Sponsor:
Eloxx Pharmaceuticals, Inc.
Collaborator:
Syneos Health